MedPath

A Study to Compare Laparoscopic to Echographic Assisted Transversus Abdominis Plane Block in Laparoscopic Colectomy

Not Applicable
Completed
Conditions
Laparoscopic Colectomy
Pain, Postoperative
Interventions
Procedure: laparoscopic-assisted Transversus Abdominis Plane (TAP) block
Procedure: ultrasound-assisted Transversus Abdominis Plane (TAP) block
Registration Number
NCT04575233
Lead Sponsor
Davide La Regina
Brief Summary

The purpose of this study is to compare the postoperative pain, the time needed and other clinical outcomes in patients who, during laparoscopic colectomy, will be injected with a local anesthetic (Ropivacaine) through an ultrasound guided technique performed by the anaesthesiologist or throught a laparoscopic assisted technique performed by the surgeon

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
116
Inclusion Criteria
  • Patients candidates to laparoscopic colorectal surgery
  • Signed informed consent
Exclusion Criteria
  • Age < 18 years old
  • Pregnancy
  • Allergy to local anaesthetics
  • Spinal or epidural analgesia
  • Acute inflammatory abdominal pathologies
  • Chronic pain syndrome
  • Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDS)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laparoscopic Transversus Abdominis Plane (L-TAP) grouplaparoscopic-assisted Transversus Abdominis Plane (TAP) blockPatients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control
Ultrasound Transversus Abdominis Plane (U-TAP) groupultrasound-assisted Transversus Abdominis Plane (TAP) blockPatients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control
Laparoscopic Transversus Abdominis Plane (L-TAP) groupRopivacainePatients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under laparoscopic control
Ultrasound Transversus Abdominis Plane (U-TAP) groupRopivacainePatients will undergo the planned laparoscopic colectomy according to the standard of treatment. A solution of 15 ml of Ropivacaine (0.2%) is then injected for postoperative pain under ultrasound control
Primary Outcome Measures
NameTimeMethod
Opioids consumption24 hours from surgery

Opioid consumption measured in morphine milligram equivalents (MME) per day

Secondary Outcome Measures
NameTimeMethod
Time required to perform the (Transversus Abdominis Plane) TAP blockduring procedure
Opioid consumption within the first 48 hours after the operation48 hours from surgery

Opioid consumption measured in morphine milligram equivalents (MME) per day

postoperative painat 3, 6, 12, 24 hours from surgery

Postoperative pain on the visual analogue scale (VAS) at 3, 6, 12, 24 hours. This visual analogue scale measures the subjective pain: patients indicate a position along a continuous line between two end-points to specify their level of pain. Absence of pain is represented by 0 while 10 corresponds to the maximum of pain.

length of hospital stayduring hospitalization,approximately 6 days

number of days the participant is being hospitalized

Trial Locations

Locations (2)

Ospedale Regionale Bellinzona e Valli, Ente Ospedaliero Cantonale

🇨🇭

Bellinzona, Switzerland

Ospedale Regionale di Lugano, Civico e Italiano - Ente Ospedaliero Cantonale

🇨🇭

Lugano, Switzerland

© Copyright 2025. All Rights Reserved by MedPath